Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Dai, Yi
REACT-AF, NCT05836987: The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation	Recruiting	3	5350	US	AFSW Guided DOAC, Apple Watch, Continuous DOAC therapy, Oral Anticoagulation therapy	Johns Hopkins University, National Heart, Lung, and Blood Institute (NHLBI)	Atrial Fibrillation	07/29	07/29
GEN6050XIIT, NCT06392724: A Study to Evaluate the Safety and Tolerability of GEN6050X in Duchenne Muscular Dystrophy.	Recruiting	1	3	RoW	GEN6050X intravenous injection	Peking Union Medical College Hospital	Duchenne Muscular Dystrophy (DMD)	12/25	12/27
NCT05187260: Antisense Oligonucleotide for Spinal Muscular Atrophy	Recruiting	N/A	1000	RoW	Nusinersen	First Affiliated Hospital of Fujian Medical University, Fujian Medical University Union Hospital, Peking Union Medical College Hospital	Spinal Muscular Atrophy	01/24	01/24